| pubmed-article:1603387 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1603387 | lifeskim:mentions | umls-concept:C0011991 | lld:lifeskim |
| pubmed-article:1603387 | lifeskim:mentions | umls-concept:C0026126 | lld:lifeskim |
| pubmed-article:1603387 | lifeskim:mentions | umls-concept:C0037713 | lld:lifeskim |
| pubmed-article:1603387 | lifeskim:mentions | umls-concept:C0001737 | lld:lifeskim |
| pubmed-article:1603387 | lifeskim:mentions | umls-concept:C0687759 | lld:lifeskim |
| pubmed-article:1603387 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:1603387 | lifeskim:mentions | umls-concept:C0038689 | lld:lifeskim |
| pubmed-article:1603387 | lifeskim:mentions | umls-concept:C0028365 | lld:lifeskim |
| pubmed-article:1603387 | lifeskim:mentions | umls-concept:C0041041 | lld:lifeskim |
| pubmed-article:1603387 | lifeskim:mentions | umls-concept:C1705493 | lld:lifeskim |
| pubmed-article:1603387 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:1603387 | lifeskim:mentions | umls-concept:C0041703 | lld:lifeskim |
| pubmed-article:1603387 | lifeskim:mentions | umls-concept:C2825812 | lld:lifeskim |
| pubmed-article:1603387 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:1603387 | pubmed:dateCreated | 1992-7-15 | lld:pubmed |
| pubmed-article:1603387 | pubmed:abstractText | A randomized treatment trial of travelers' diarrhea was carried out among U.S. military personnel participating in routine exercises in several port cities in South America and West Africa. A 5-day, twice daily course of either norfloxacin (400 mg) or trimethoprim/sulfamethoxazole (TMP/SMX, 160/800 mg) was given to 142 volunteers. At the end of 5 days of treatment, diarrhea had resolved in 100% of 73 patients receiving norfloxacin and 97.1% (67/69) receiving TMP/SMX. A probable bacterial pathogen was determined in 44% of 142 subjects: 49% of the norfloxacin group and 39% of the TMP/SMX group. The most common pathogens detected were enterotoxigenic Escherichia coli in 20% of cases and rotavirus in 15%. Resistance to TMP/SMX was present in 20 (27%) bacterial isolates, while no resistance to norfloxacin was found. Eight of 10 patients in the TMP/SMX treatment group who had TMP/SMX-resistant bacterial enteropathogens improved clinically. Both norfloxacin and TMP/SMX were clinically effective in the treatment of travelers' diarrhea in this military population. | lld:pubmed |
| pubmed-article:1603387 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1603387 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1603387 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1603387 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1603387 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1603387 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1603387 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:1603387 | pubmed:issn | 0026-4075 | lld:pubmed |
| pubmed-article:1603387 | pubmed:author | pubmed-author:BourgeoisA... | lld:pubmed |
| pubmed-article:1603387 | pubmed:author | pubmed-author:KilpatrickM... | lld:pubmed |
| pubmed-article:1603387 | pubmed:author | pubmed-author:HyamsK CKC | lld:pubmed |
| pubmed-article:1603387 | pubmed:author | pubmed-author:BatchelorR... | lld:pubmed |
| pubmed-article:1603387 | pubmed:author | pubmed-author:BurrD HDH | lld:pubmed |
| pubmed-article:1603387 | pubmed:author | pubmed-author:ThorntonS ASA | lld:pubmed |
| pubmed-article:1603387 | pubmed:author | pubmed-author:GardinerCC | lld:pubmed |
| pubmed-article:1603387 | pubmed:author | pubmed-author:OprandyJ JJJ | lld:pubmed |
| pubmed-article:1603387 | pubmed:author | pubmed-author:WignallS FSF | lld:pubmed |
| pubmed-article:1603387 | pubmed:author | pubmed-author:GarstPP | lld:pubmed |
| pubmed-article:1603387 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1603387 | pubmed:volume | 157 | lld:pubmed |
| pubmed-article:1603387 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1603387 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1603387 | pubmed:pagination | 55-8 | lld:pubmed |
| pubmed-article:1603387 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:1603387 | pubmed:meshHeading | pubmed-meshheading:1603387-... | lld:pubmed |
| pubmed-article:1603387 | pubmed:meshHeading | pubmed-meshheading:1603387-... | lld:pubmed |
| pubmed-article:1603387 | pubmed:meshHeading | pubmed-meshheading:1603387-... | lld:pubmed |
| pubmed-article:1603387 | pubmed:meshHeading | pubmed-meshheading:1603387-... | lld:pubmed |
| pubmed-article:1603387 | pubmed:meshHeading | pubmed-meshheading:1603387-... | lld:pubmed |
| pubmed-article:1603387 | pubmed:meshHeading | pubmed-meshheading:1603387-... | lld:pubmed |
| pubmed-article:1603387 | pubmed:meshHeading | pubmed-meshheading:1603387-... | lld:pubmed |
| pubmed-article:1603387 | pubmed:meshHeading | pubmed-meshheading:1603387-... | lld:pubmed |
| pubmed-article:1603387 | pubmed:meshHeading | pubmed-meshheading:1603387-... | lld:pubmed |
| pubmed-article:1603387 | pubmed:meshHeading | pubmed-meshheading:1603387-... | lld:pubmed |
| pubmed-article:1603387 | pubmed:meshHeading | pubmed-meshheading:1603387-... | lld:pubmed |
| pubmed-article:1603387 | pubmed:meshHeading | pubmed-meshheading:1603387-... | lld:pubmed |
| pubmed-article:1603387 | pubmed:meshHeading | pubmed-meshheading:1603387-... | lld:pubmed |
| pubmed-article:1603387 | pubmed:meshHeading | pubmed-meshheading:1603387-... | lld:pubmed |
| pubmed-article:1603387 | pubmed:meshHeading | pubmed-meshheading:1603387-... | lld:pubmed |
| pubmed-article:1603387 | pubmed:meshHeading | pubmed-meshheading:1603387-... | lld:pubmed |
| pubmed-article:1603387 | pubmed:meshHeading | pubmed-meshheading:1603387-... | lld:pubmed |
| pubmed-article:1603387 | pubmed:meshHeading | pubmed-meshheading:1603387-... | lld:pubmed |
| pubmed-article:1603387 | pubmed:meshHeading | pubmed-meshheading:1603387-... | lld:pubmed |
| pubmed-article:1603387 | pubmed:year | 1992 | lld:pubmed |
| pubmed-article:1603387 | pubmed:articleTitle | Norfloxacin compared to trimethoprim/sulfamethoxazole for the treatment of travelers' diarrhea among U.S. military personnel deployed to South America and West Africa. | lld:pubmed |
| pubmed-article:1603387 | pubmed:affiliation | Department of Infectious Diseases, U.S. Naval Medical Research Institute, Bethesda, MD. | lld:pubmed |
| pubmed-article:1603387 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1603387 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:1603387 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:1603387 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
| pubmed-article:1603387 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
